Table 3 Qualitative variables of the subjects as a function of the diagnosis of premorbid metabolic syndrome based on the WHO proposal
From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
|  |  | Total n = 621 | Pre-MetS n = 136 | Non Pre-MetS n = 485 | p |
|---|---|---|---|---|---|
Sex | ♂ | 48.0 (44.1-51.9) | 55.9 (47.6-64.2) | 45.8 (41.4-50.2) |  |
|  | ♀ | 52.0 (48.1-55.9) | 44.1 (35.8-52.4) | 54.2 (49.8-58.6) | <0.001 |
AC drugs | Â | 30.0 (26.4-33.6) | 49.3 (40.9-57.7) | 24.5 (20.7-28.3) | <0.001 |
AH drugs | Â | 32.7 (29.0-36.4) | 49.3 (40.9-57.7) | 28.0 (24.0-32.0) | <0.001 |
Smoking habit | Â | 30.1 (26.5-33.7) | 27.9 (20.4-35.4) | 30.7 (26.6-34.8) | 0.597 |
Physical inactivity | Â | 58.9 (55.0-62.8) | 69.9 (62.2-77.6) | 55.9 (51.5-60.3) | 0.004 |
BMI | <25 | 42.4 (38.5-46.3) | 12.5 (7.0-18.1) | 50.7 (46.6-55.2) | Â |
|  | ≥25 | 57.6 (53.7-61.5) | 87.5 (81.9-93.1) | 49.3 (44.9-53.7) | <0.001 |